Vivoryon Therapeutics N.V. (VVY.AS)

EUR 1.97

(0.71%)

Revenue Summary of Vivoryon Therapeutics N.V.

  • Vivoryon Therapeutics N.V.'s latest annual revenue in 2023 was -3.62 Million EUR , down 0.0% from previous year.
  • Vivoryon Therapeutics N.V.'s latest quarterly revenue in 2024 Q2 was - EUR , down 0.0% from previous quarter.
  • Vivoryon Therapeutics N.V. reported a annual revenue of - EUR in annual revenue 2022, down -100.0% from previous year.
  • Vivoryon Therapeutics N.V. reported a annual revenue of 10.76 Million EUR in annual revenue 2021, down 0.0% from previous year.
  • Vivoryon Therapeutics N.V. reported a quarterly revenue of -3.62 Million EUR for 2023 FY, down 0.0% from previous quarter.
  • Vivoryon Therapeutics N.V. reported a quarterly revenue of - EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Vivoryon Therapeutics N.V. (2023 - 2011)

Historical Annual Revenue of Vivoryon Therapeutics N.V. (2023 - 2011)

Year Revenue Revenue Growth
2023 -3.62 Million EUR 0.0%
2022 - EUR -100.0%
2021 10.76 Million EUR 0.0%
2020 - EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%
2017 - EUR 0.0%
2016 - EUR 0.0%
2015 - EUR 0.0%
2014 - EUR 0.0%
2013 - EUR -100.0%
2012 6000.00 EUR -71.43%
2011 21 Thousand EUR 0.0%

Peer Revenue Comparison of Vivoryon Therapeutics N.V.

Name Revenue Revenue Difference
ABIONYX Pharma SA 4.64 Million EUR 178.017%
ABIVAX Société Anonyme 4.62 Million EUR 178.338%
Adocia SA 2.15 Million EUR 268.372%
Aelis Farma SA 9.05 Million EUR 139.982%
Biophytis S.A. - EUR Infinity%
Advicenne S.A. 3.15 Million EUR 214.884%
genOway Société anonyme 20.04 Million EUR 118.058%
IntegraGen SA 12.53 Million EUR 128.874%
Medesis Pharma S.A. 300.03 Thousand EUR 1306.53%
Neovacs S.A. 533.41 Thousand EUR 778.65%
NFL Biosciences SA - EUR Infinity%
Plant Advanced Technologies SA 1.68 Million EUR 315.282%
Quantum Genomics Société Anonyme 19.79 Thousand EUR 18386.523%
Sensorion SA 4.74 Million EUR 176.322%
Theranexus Société Anonyme 296.33 Thousand EUR 1321.607%
TME Pharma N.V. 17 Thousand EUR 21394.118%
Valbiotis SA 4.73 Million EUR 176.484%
TheraVet SA 1.07 Million EUR 435.79%
Valerio Therapeutics Société anonyme 1.8 Million EUR 301.111%
argenx SE 1.13 Billion EUR 100.319%
BioSenic S.A. 543 Thousand EUR 766.667%
Celyad Oncology SA 102 Thousand EUR 3649.02%
DBV Technologies S.A. - EUR Infinity%
Galapagos NV 239.72 Million EUR 101.51%
Genfit S.A. 28.56 Million EUR 112.673%
GeNeuro SA - EUR Infinity%
Hyloris Pharmaceuticals SA 2.08 Million EUR 273.455%
Innate Pharma S.A. 51.9 Million EUR 106.975%
Inventiva S.A. 17.47 Million EUR 120.713%
MaaT Pharma SA 2.22 Million EUR 262.478%
MedinCell S.A. 9.16 Million EUR 139.52%
Nanobiotix S.A. 30.05 Million EUR 112.043%
Onward Medical N.V. 532 Thousand EUR 780.451%
Oryzon Genomics S.A. 14.19 Million EUR 125.508%
OSE Immunotherapeutics SA 2.22 Million EUR 262.551%
Oxurion NV 263 Thousand EUR 1476.426%
Pharming Group N.V. 245.31 Million EUR 101.476%
Poxel S.A. 1.98 Million EUR 282.736%
GenSight Biologics S.A. 1.26 Million EUR 385.714%
Transgene SA 1.18 Million EUR 405.743%
Financière de Tubize SA - EUR Infinity%
UCB SA 5.25 Billion EUR 100.069%
Valneva SE 153.71 Million EUR 102.355%